Yunus Emre Tarhan, M.D. Clinical Assistant Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Yunus Emre Tarhan, M.D., is a Clinical Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. His clinical interests include acute care delivery in hospital medicine, hospital-based cancer care, patient education and teaching, and health care policy and equity. Originally from Turkey, Dr. Tarhan earned his medical degree at Istanbul University. He completed internal medicine residency training at Mass General Brigham's Salem Hospital in Massachusetts and a postdoctoral research fellowship at the University of Chicago. Dr. Tarhan's research interests include cancer biomarker discovery, the influence of genetics on cardiovascular disease, personalized oncotherapy, and tumor microenvironment. Dr. Tarhan has contributed to the book Cancer Science, presented his findings at scientific conferences throughout the United States, and published work in various scientific journals. Certified by the American Board of Internal Medicine, Dr. Tarhan joined the UT Southwestern faculty in 2024. Personal Note Outside of work, Dr. Tarhan is a history buff who enjoys reading, learning about the past, and completing online training sessions. In addition, he participates in health missions to Africa and is a founding partner of a company that specializes in patient education and health delivery systems. Education Medical School Istanbul University-Cerrahpasa, Turkey (2014) Residency Mass General Brigham Salem Hospital (2020), Internal Medicine Research Interest Acute care delivery in Hospital Medicine Cancer biomarker discovery Healthcare policy Influence of genetics on cardiovascular disease Patient education and teaching Tumor microenvironment Publications Featured Publications Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells. Deng B, Tarhan YE, Ueda K, Ren L, Katagiri T, Park JH, Nakamura Y Neoplasia 2018 Oct 20 10 1038-1044 p53-independent p21 induction by MELK inhibition. Matsuda T, Kato T, Kiyotani K, Tarhan YE, Saloura V, Chung S, Ueda K, Nakamura Y, Park JH, Oncotarget 2017 Aug 8 35 57938-57947 Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy. Park JH, Jang M, Tarhan YE, Katagiri T, Sasa M, Miyoshi Y, Kalari KR, Suman VJ, Weinshilboum R, Wang L, Boughey JC, Goetz MP, Nakamura Y Int. J. Oncol. 2016 Aug 49 2 471-8 Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown. Tarhan YE, Kato T, Jang M, Haga Y, Ueda K, Nakamura Y, Park JH, Neoplasia 2016 May 18 5 265-272 Results 1-4 of 4 1 Books Featured Books Critical role of O-glycosylation of estrogen receptor alpha by GALNT6 in breast cancer cells. In Cancer Science Deng B, Tarhan YE, Ren L, Ueda K, Katagiri T, Park JH, Nakamura Y. (2018). Hoboken, NJ, Wiley Professional Associations/Affiliations American Association for Cancer Reserarch American College of Physicians American Medical Association American Society of Clinical Oncology Society of Hospital Medicine
